Sandler Alan B.'s Form 4 filing
Revolution Medicines, Inc. (RVMD) · filed Sep 18, 2026
- Accession no.
- 0001835966-26-000006
- Filed
- Sep 18, 2026, 6:06 PM ET
- Trade date
- Sep 16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $67.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sandler Alan B.CIK 0001835966 | Officer (Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | SSaleDisposed | −5 | $194.96 | −$974.79 | 53,204 | Direct | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −336 | $199.30 | −$66,965.88 | 52,868 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.